or Try an Advanced Search...

    Technical Analysis for ALMS - Alumis Inc.

    Grade Last Price % Change Price Change
    B 11.90 -0.58% -0.07
    ALMS closed down 0.58 percent on Friday, October 25, 2024, on 37 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Up
    Historical ALMS trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Inside Day Range Contraction -0.58%
    Wide Bands Range Expansion -0.58%
    Gapped Up Strength -0.58%
    Overbought Stochastic Strength -0.58%
    Stochastic Sell Signal Bearish -1.16%
    Upper Bollinger Band Walk Strength -1.16%
    Wide Bands Range Expansion -1.16%
    Older End-of-Day Signals for ALMS ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Down 1% 2 days ago
    Up 3% 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ALMS Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Autoimmune Disease Drug Development Autoimmunity Syndromes Personalized Medicine Sjögren Syndrome

    Is ALMS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 9 Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
    Oct 4 Alumis: Could This Broken Immunology IPO Become The Next Amgen?
    Sep 27 Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
    Sep 16 Alumis: Recent IPO With Differentiated Data In Autoimmune Diseases
    Sep 3 Alumis to Participate in Upcoming September Investor Conferences
    Aug 14 Alumis reports Q2 results
    Aug 13 Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
    Jul 29 Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
    Jun 28 Alumis, in trading debut, falls 22% from IPO price
    Jun 28 Alumis prices IPO at $16 per share
    See more ALMS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.53
    52 Week Low 9.5401
    Average Volume 161,436
    200-Day Moving Average 0.00
    50-Day Moving Average 11.61
    20-Day Moving Average 11.03
    10-Day Moving Average 11.73
    Average True Range 0.76
    RSI (14) 55.16
    ADX 23.09
    +DI 21.82
    -DI 15.72
    Chandelier Exit (Long, 3 ATRs) 10.82
    Chandelier Exit (Short, 3 ATRs) 11.83
    Upper Bollinger Bands 12.82
    Lower Bollinger Band 9.24
    Percent B (%b) 0.74
    BandWidth 32.44
    MACD Line 0.23
    MACD Signal Line 0.04
    MACD Histogram 0.196
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.74
    Resistance 3 (R3) 12.80 12.58 12.60
    Resistance 2 (R2) 12.58 12.37 12.55 12.55
    Resistance 1 (R1) 12.24 12.23 12.13 12.18 12.51
    Pivot Point 12.02 12.02 11.97 11.99 12.02
    Support 1 (S1) 11.68 11.81 11.57 11.62 11.29
    Support 2 (S2) 11.46 11.67 11.43 11.25
    Support 3 (S3) 11.12 11.46 11.20
    Support 4 (S4) 11.06